PONTREMOLI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 27.041
AS - Asia 844
SA - Sud America 168
NA - Nord America 112
AF - Africa 11
OC - Oceania 2
Totale 28.178
Nazione #
IT - Italia 27.016
SG - Singapore 388
CN - Cina 243
VN - Vietnam 146
BR - Brasile 100
US - Stati Uniti d'America 93
AR - Argentina 44
HK - Hong Kong 28
MX - Messico 15
ID - Indonesia 8
RU - Federazione Russa 8
BD - Bangladesh 6
CO - Colombia 6
IQ - Iraq 6
EC - Ecuador 5
PK - Pakistan 5
VE - Venezuela 5
PY - Paraguay 4
CL - Cile 3
DE - Germania 3
GB - Regno Unito 3
IN - India 3
ZA - Sudafrica 3
AU - Australia 2
AZ - Azerbaigian 2
CA - Canada 2
DZ - Algeria 2
IE - Irlanda 2
KE - Kenya 2
MA - Marocco 2
NL - Olanda 2
SA - Arabia Saudita 2
UA - Ucraina 2
AL - Albania 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 28.178
Città #
Genova 16.085
Genoa 6.800
Rapallo 2.117
Vado Ligure 1.761
Singapore 203
Milan 84
Beijing 72
Ho Chi Minh City 59
Bordighera 39
Hanoi 33
Ashburn 28
Hong Kong 28
Council Bluffs 17
Tianjin 16
Mexico City 11
Rome 10
The Dalles 9
Naples 8
São Paulo 8
Bologna 6
North Charleston 6
Biên Hòa 5
Da Nang 5
Florence 5
Hải Dương 5
Turin 5
Bari 4
Haiphong 4
New York 4
Padua 4
Boardman 3
Buenos Aires 3
Bắc Ninh 3
Cazzago San Martino 3
City of London 3
Curitiba 3
Laferrere 3
Posadas 3
Rio de Janeiro 3
Thái Bình 3
Asunción 2
Baku 2
Bogotá 2
Brasília 2
Cape Town 2
Cesena 2
Chengdu 2
Chittagong 2
Ciserano 2
Cotia 2
Dublin 2
Embu das Artes 2
Goiânia 2
Guangzhou 2
Jakarta 2
La Rioja 2
Lahore 2
Lainate 2
Lomas de Zamora 2
Los Angeles 2
Mariano Moreno 2
Melbourne 2
Monte Grande 2
Moscow 2
Nairobi 2
Nuremberg 2
Palermo 2
Pescara 2
Phú Thọ 2
Phủ Lý 2
Quảng Ngãi 2
Rimini 2
Rostov-on-Don 2
Santiago de Cali 2
Santo André 2
Senago 2
Verona 2
Vinh 2
Vĩnh Tường 2
Abha 1
Abreu e Lima 1
Acari 1
Acarigua 1
Americana 1
Antakya 1
Arica 1
Arzano 1
As Samawah 1
Atessa 1
Athens 1
Atri 1
Avaré 1
Bab Ezzouar 1
Baghdad 1
Banfield 1
Bangkok 1
Barquisimeto 1
Barra do Piraí 1
Basra 1
Batam 1
Totale 27.570
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 281
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 246
Left ventricular dilatation and subclinical renal damage in primary hypertension 224
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 190
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 187
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 185
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 183
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 177
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 176
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 175
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 173
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 173
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 170
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 169
C-reactive protein and target organ damage in untreated patients with primary hypertension. 165
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 163
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 162
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 161
Cardiovascular and renal effects of hyperuricaemia and gout. 160
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 160
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 157
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 156
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 156
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 156
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 154
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 154
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 154
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 154
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 153
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 153
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 151
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 151
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 150
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 148
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 148
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 147
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 147
Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. 146
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 145
Amino acid imbalance in patients with chronic renal failure. 145
Microalbuminuria in primary hypertension: a guide to optimal patient management? 145
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 144
Blood pressure variability and multiple organ damage in primary hypertension 143
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 143
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 143
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 142
Creatinine clearance and early signs of target organ damage in primary hypertension 141
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 141
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 140
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 139
Post-biopsy arteriovenous fistulas of the native kidneys diagnosed by Doppler US 139
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 139
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 138
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 138
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 138
Use of nifedipine in the treatment of hypertension. 137
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 137
Sub-clinical organ damage in hypertension and obesity 137
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 137
Role of the fixed-dose combination lercanidipine-enalapril in renal protection. 135
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 135
Mild renal dysfunction and renal vascular resistance in primary hypertension 135
Hyperuricemia and renal risk 135
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 134
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 133
Highlights from International Congress 133
Albuminuria: The kidney message on cardiovascular health 133
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 133
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 133
Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans 132
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 132
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 131
Application of Temporary Filter During Percutaneous Transcatheter Embolization with Macro Coils of High-flow Massive Renal Arteriovenous Fistula 131
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 131
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 131
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 131
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 130
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 130
Insulin activation of red blood cell Na+/H+ exchange decreases the affinity of sodium sites. 129
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 129
Renal and cardiac abnormalities in primary hypertension 129
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 129
Nephrolithiasis by Corynebacterium urealyticum infection: Literature review and case report 129
Exploring New Options for Cardiovascular Disease Prevention May Improve Patients’ Quality of Life and Outcomes 129
Renal ammoniagenesis in man with chronic potassium depletion. 128
Overall health assessment: a renal perspective. 128
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 128
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 128
Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis 128
Hyperuricemia is associated with increased hospitalization risk and healthcare costs: Evidence from an administrative database in Italy 128
Diffusion-weighted MRI sequences (DW-MRI) of the kidney: normal findings, influence of hydration state and repeatibility of results 127
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 127
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 126
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 125
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 125
Chronic kidney disease and albuminuria in arterial hypertension. 125
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 125
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease 124
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 124
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 124
Totale 14.678
Categoria #
all - tutte 95.929
article - articoli 95.068
book - libri 0
conference - conferenze 0
curatela - curatele 512
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 349
Totale 191.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.420 0 0 0 0 0 169 209 226 188 260 157 211
2021/20222.755 91 142 136 289 118 279 175 652 148 286 110 329
2022/20232.596 263 155 24 272 382 467 47 209 444 62 212 59
2023/20241.396 71 198 36 145 133 266 72 83 82 14 93 203
2024/20254.503 100 343 148 297 598 453 428 702 228 227 459 520
2025/20263.735 888 353 629 720 1.081 64 0 0 0 0 0 0
Totale 28.788